Lidocaine patches after cesarean sections: a randomized control trial

Area of Science:

• Obstetrics and Gynecology
• Pain Management
• Anesthesiology

Background:

• Topical lidocaine patches are a common analgesic, but their efficacy in post-cesarean pain management is not well-established.
• Investigating novel pain relief strategies is crucial for improving patient outcomes after cesarean delivery.

Purpose of the Study:

• To evaluate the effect of adding topical lidocaine patches to standard care on pain scores and opioid consumption in patients following cesarean delivery.
• To assess the safety and patient satisfaction with lidocaine patch use in the postpartum period.

Main Methods:

• A prospective, randomized, subject-blinded controlled trial was conducted with 100 patients undergoing cesarean delivery.
• Participants were randomized to receive either a lidocaine patch or a placebo patch.
• Primary outcomes included visual analog scale (VAS) pain scores and total morphine equivalents used postoperatively.

Main Results:

• No significant difference in mean maximum or average VAS pain scores was observed between the lidocaine patch and placebo groups on postoperative days 1-4.
• Opioid consumption (morphine equivalents) also did not differ significantly between the groups.
• While not statistically significant, 63% of patients in the lidocaine group expressed a desire for future use, with 0% reporting care disruption.

Conclusions:

• The addition of topical lidocaine patches to routine care did not significantly reduce pain or opioid use after cesarean delivery.
• Further investigation into non-opioid pain management options is warranted for the postpartum period.
• Lidocaine patches may offer a safe option for some patients, but did not demonstrate significant analgesic benefits in this study population.